We are live on
!
Find out more
EMFAT
Emerald Mutual Fund Advisers Trust Portfolio holdings
AUM
$2.85B
1-Year Est. Return
140.52%
This Fund
S&P 500
This Quarter
Est. Return
+29.08%
1 Year Est. Return
+140.52%
3 Year Est. Return
+478.17%
5 Year Est. Return
+660.56%
10 Year Est. Return
+4,974.42%
AUM
$1.64B
AUM Growth
+$233M
(+17%)
Cap. Flow
+$1.77M
Cap. Flow
% of AUM
0.11%
Top 10 Holdings %
Top 10 Hldgs %
22.04%
Holding
239
New
31
Increased
63
Reduced
70
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LFSC
F/m Emerald Life Sciences Innovation ETF
LFSC
|
+$45.7M |
| 2 |
Mercury Systems
MRCY
|
+$12.8M |
| 3 |
Mirum Pharmaceuticals
MIRM
|
+$9.69M |
| 4 |
Corcept Therapeutics
CORT
|
+$8.2M |
| 5 |
Onto Innovation
ONTO
|
+$8.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
FTAI Aviation
FTAI
|
+$30.3M |
| 2 |
Insmed
INSM
|
+$25.1M |
| 3 |
BPMC
Blueprint Medicines
BPMC
|
+$22.1M |
| 4 |
GTLS
Chart Industries
GTLS
|
+$14.7M |
| 5 |
Credo Technology Group
CRDO
|
+$14.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.67% |
| 2 | Healthcare | 21.58% |
| 3 | Industrials | 16.91% |
| 4 | Financials | 16% |
| 5 | Consumer Discretionary | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Orrstown Financial Services
ORRF
$838M
| – | – |
-48,861
| Closed | -$1.47M |
|
227
Pinterest
PINS
$13.4B
| – | – |
-4,883
| Closed | -$151K |
|
228
Quanterix
QTRX
$190M
| – | – |
-8,277
| Closed | -$53.9K |
|
|
SNV
229
DELISTED
Synovus
SNV
| – | – |
-10,408
| Closed | -$486K |
|
230
Sarepta Therapeutics
SRPT
$1.77B
| – | – |
-21,386
| Closed | -$1.36M |
|
231
Stewart Information Services
STC
$2.08B
| – | – |
-40,902
| Closed | -$2.92M |
|
232
Uranium Energy
UEC
$5.57B
| – | – |
-256,309
| Closed | -$1.23M |
|
233
Cactus
WHD
$5.44B
| – | – |
-124,407
| Closed | -$5.7M |
|
234
Select Water Solutions
WTTR
$2.61B
| – | – |
-16,320
| Closed | -$171K |
|
235
Zions Bancorporation
ZION
$10.3B
| – | – |
-4,828
| Closed | -$241K |
|
236
Astera Labs
ALAB
$58B
| – | – |
-1,781
| Closed | -$106K |
|
|
SASR
237
DELISTED
Sandy Spring Bancorp Inc
SASR
| – | – |
-8,088
| Closed | -$226K |
|
Similar funds
SAI
MSDF
AIP
YC
AHSSHC
CAM
GS
ISL
Emerald Mutual Fund Advisers Trust's Q2 2025 Portfolio in Review
As of Q2 2025, Emerald Mutual Fund Advisers Trust held 239 positions worth $1.64B, up 17% from $1.41B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Emerald Mutual Fund Advisers Trust's Q2 2025 filing shows 31 new, 63 increased, 70 reduced and 28 closed positions. Its largest new stake was F/m Emerald Life Sciences Innovation ETF: 1,997,035 shares worth $49.2M. The largest sale was FTAI Aviation, an estimated $30.3M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Emerald Mutual Fund Advisers Trust's largest Q2 2025 buy was F/m Emerald Life Sciences Innovation ETF: 1,997,035 shares worth $49.2M.
- Emerald Mutual Fund Advisers Trust added most to Corcept Therapeutics in Q2 2025, an estimated $8.2M increase.
- Emerald Mutual Fund Advisers Trust's biggest Q2 2025 reduction was FTAI Aviation, cutting an estimated $30.3M.
- Emerald Mutual Fund Advisers Trust fully exited Blueprint Medicines in Q2 2025, selling an estimated $22.1M.
- Emerald Mutual Fund Advisers Trust's ten largest holdings make up 22% of its $1.64B portfolio in Q2 2025.
- Emerald Mutual Fund Advisers Trust opened 31 new positions and closed 28 in Q2 2025.
- Emerald Mutual Fund Advisers Trust's portfolio value rose 17% quarter-over-quarter to $1.64B.
Based on Emerald Mutual Fund Advisers Trust's 13F filing for Q2 2025, filed 4 Aug 2025.